Quick Answer
PLUS THERAPEUTICS, INC. reported Shares Outstanding of 138.68 million shares for fiscal year 2025.
PLUS THERAPEUTICS, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 138.68M | +2251.9% |
| 2024 | 5.90M | +32.7% |
| 2023 | 4.44M | -88.1% |
| 2023 | 37.40M | +1569.6% |
| 2022 | 2.24M | -85.6% |
| 2021 | 15.51M | +129.8% |
| 2020 | 6.75M | +73.9% |
| 2019 | 3.88M | +1208.3% |
| 2018 | 296,609 | -95.2% |
| 2018 | 6.20M | +7.2% |
| 2017 | 5.78M | -73.4% |
| 2016 | 21.71M | +63.2% |
| 2016 | 13.30M | +2.3% |
| 2015 | 13.00M | -86.9% |
| 2014 | 99.35M | +39.3% |
| 2013 | 71.31M | +8.2% |
| 2012 | 65.91M | +16.5% |
| 2011 | 56.59M | +8.9% |
| 2010 | 51.96M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 131.61M | +2132.0% | +42.8% |
| June 30, 2025 | 92.18M | +1516.0% | +442.2% |
| March 31, 2025 | 17.00M | +298.7% | +188.3% |
| December 31, 2024 | 5.90M | +32.7% | +0.0% |
| September 30, 2024 | 5.90M | +30.4% | +3.4% |
| June 30, 2024 | 5.70M | +98.1% | +33.8% |
| March 31, 2024 | 4.26M | -88.2% | -4.0% |
| December 31, 2023 | 4.44M | — | -1.7% |
- PLUS THERAPEUTICS, INC. showed an increase of +2251.9% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, PLUS THERAPEUTICS, INC.’s shares outstanding has grown by 166.9% (from 51.96 million shares to 138.68 million shares).
- The most recent figure is from PLUS THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: